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The ACCO gene from Lycopersicon esculentum (tomato) has been cloned into the expression
vector PT7-7. The highly expressed protein was recovered in the form of inclusion bodies. ACCO
is inactivated by diethyl pyrocarbonate (DEPC) with a second-order rate constant of 170 M-1
min-1. The pH-inactivation rate data imply the involvement of an amino acid residue with a pK
value of 6.05. The difference UV spectrum of the the DEPC-inactivated versus native ACCO
showed a single peak at 242 nm indicating the modification of histidine residues. The inactivation
was reversed by the addition of hydroxylamine to the DEPC-inactivated ACCO. Substrate/cofactor
protection studies indicate that both iron and ACC bind near the active site, which contains histidine
residues. Four histidines of ACCO were individually mutated to alanine and glycine. H39A is
catalytically active, while H177A, H177G, H211A, H211G, H234A, and H234G are basically
inactive. The results indicate that histidine residues 177, 211, and 234 may serve as ligands for
the active-site iron of ACCO and/or may play some important structural or catalytic role.
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1. INTRODUCTION
Ethylene, the simplest alkene, is a phytohormone that
plays a key role in plant growth and development, in-
cluding fruit ripening, abscission, and senescence
(Abeles et al., 1992; Mattoo and Suttle, 1991). Ethylene
is synthesized from methionine via S-adenosylmethion-
ine (SAM).3 The 2-aminobutanoic acid portion of SAM
is cyclized to 1-aminocyclopropane-l-carboxylic acid
(ACC) by the pyridoxal-phosphate-utilizing enzyme
1 Interdepartmental Program in Medicinal Chemistry, College of Phar-
macy, University of Michigan, Ann Arbor, Michigan 48109-1065.
2To whom correspondence should be addressed.
3Abbreviations: ACC, 1-aminocyclopropane-l-carboxylic acid;
DEPC, diethylpyrocarbonate; DTT, dithiothreitol; EFE, ethylene-
forming enzyme; EDTA, [ethylene-bis(oxyethylenenitrilo)]tetraacetic
acid; HEPES, 4-(2-hydroxyethyl)-l-piperazine ethanesulfonic acid;
IPNS, isopenicillin-N-synthase; SAM, S-adenosylmethionine; SDS-
PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis;
TRIS, tris(hydroxymethyl)aminomethane.
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ACC synthase (Kende, 1993; Yang and Hoffman, 1984).
Ethylene-forming enzyme (EFE) [1-aminocyclopropane-
1-carboxylic acid oxidase (ACCO)] catalyzes the final
step in the biosynthesis of ethylene by the oxidation of
ACC to ethylene (Kende, 1993; Yang and Hoffman,
1984).
Until recently, the isolation and biochemical char-
acterization of ACCO was impeded due to enzyme in-
stability during homogenization procedures. Hamilton et
al. (1990) showed that the pTOM13 antisense gene sig-
nificantly reduced ACCO activity in tomato fruits, sug-
gesting that the tomato pTOM13 gene product was
related to ACCO. The cDNA of ACCO showed se-
quence homology to flavanone-33-hydroxylase, which
required Fe2+, A-ketoglutarate, and ascorbate for activity
(Hamilton et al., 1990). This led Ververidis and John
(1991) to demonstrate ACCO activity in vitro by the
inclusion of Fe2+ and ascorbate in the assay of their en-
zyme. Subsequently, ACCO was obtained in partially
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purified or pure preparation from apple (Dilley et al.,
1993; Dong et al., 1992a, b; Dupille et al., 1992; Fer-
nandez-Maculet and Yang, 1992; Kuai and Dilley, 1992;
Pirrung et al., 1993), avocado (McGarvey and
Christoffersen, 1992), melon fruits (Smith et al., 1992),
and pear (Vioque and Castellano, 1994). ACCO activity
has been expressed in yeast (Hamilton et al., 1991) and
Xenopus oocytes (Spanu et al., 1991) and most recently
in Escherichia coli (Zhang et al., 1995).
In the present paper, we describe the high-level
overexpression of Lycopersicon esculentum (tomato)
ACCO in E. coli in the form of inclusion bodies and the
solubilization of ACCO inclusion bodies by sodium
deoxycholate or guanidinium hydrochloride. We provide
chemical and kinetic evidence for the involvement of the
histidine residues in ACCO catalysis as evidenced by the
pH dependence of inactivation, substrate protection stud-
ies, reactivation of DEPC-inactivated enzyme by hy-
droxylamine, and detection of N-carbethoxyhistidine by
UV difference spectra. Finally, results from mutagenic
studies are presented that suggest histidine 177 and 234
are possible ligands involved in binding of the iron at
the active site of ACCO, while histidine 211 may be
involved with either catalysis or structure.
2. MATERIALS AND METHODS
Restriction and DNA modifying enzymes were
from Boehringer Mannheim. The pCR-Script SK(+)
cloning kit and the Quik-Change Site-directed Mutage-
nesis Kit were purchased from Stratagene Cloning Sys-
tem, Inc. The E. coli strain BL 21 (DE 3) was obtained
from Novagen. Imidazole, sodium deoxycholate, and
diethylpyrocarbonate were from Sigma Chemical Com-
pany. The 1-aminocyclopropane-l-carboxylic acid was
purchased from Calbiochem (LaJolla, CA); hydroxyla-
mine from Aldrich Chemical Co.; ferrous sulfate from
Alfa (Ward Hill, MA); and guanidinium hydrochloride
from Gibco BRL (Gaithersburg, MD). TGI cells were
obtained from Dr. Jack Dixon of the Biological Chem-
istry Department at the University of Michigan. The
pYES plasmid containing the pRC13 insert (pYTE2)
was a gift from Dr. Hans Kende of the Plant Biochem-
istry Department at Michigan State University. The pT7-
7 was obtained from Dr. Stanley Tabor of the Harvard
Medical School. The PCR amplification was performed
using an MJR Research Thermal cycler. Oligonucleo-
tides were synthesized by the University of Michigan
Biomedical Research Resources Core Facility. DNA and
protein sequencing as well as electrospray mass spectral
analysis and total amino acid content were also carried
out by the University of Michigan Biomedical Research
Resources Core Facility. The GeneAmp kit was from
Perkin-Elmer/Cetus, except that recombinant Pfu DNA
polymerase (Strategene Cloning Systems, Buffer #1)
was substituted for Taq DNA polymerase. Promega
DNA and PCR purification kits were utilized.
2.1. PCR Cloning of ACCO
Two primers were constructed to correspond to the
5' and 3' ends of the open reading frame previously iden-
tified as the pRC13 (corrected pTOM13) (Hamilton et
al., 1991). The 5' sequence was
GATTCTAGAATTCATATGGAGAACTTCCCAATTATT
The 3' sequence was
GATTCTGAATTCGGATCCCTAAGCACTTGC
The forward primer incorporated an Ndel site (under-
lined) and the reverse primer a BamHI (underlined) site
for cloning into the expression vector pT7-7, constructed
by Dr. Stanley Tabor at the Harvard Medical School.
The tomato ACCO gene was amplified from the plasmid
pYTE2 by PCR. The annealing temperature was 50°C.
After 25 cycles, the amplified DNA was purified by the
Promega PCR purification kit. The purified PCR product
was cloned into pCR-Script following the procedure de-
scribed by the Stratagene Co. to give pCR-Script-EFE.
The desired fragment containing the pRC13 portion of
the pCR-Script-EFE was excised by restriction digestion
with Ndel/BamRl and subcloned into the comparably
restricted pT7-7. Chemically competent E. coli TGI
cells were transformed with the ligated plasmid, and re-
Scheme 1. Reaction catalyzed by 1-aminocyclopropane-l-carboxylic acid synthase.
Essential Histidine Residues in ACCO 57
striction digest of the resulting constructs isolated from
the TGI cells revealed an insert of 0.95 kb in the vector.
Plasmid DNA, pT7-7-EFE, purified from one of these
transformants was used to transform chemically com-
petent BL21(DE3) cells (Novagen, Inc.). The correct se-
quence (Hamilton et al., 1991) of pT7-7-EFE was
confirmed by automated sequencing on an Applied Bio-
systems 373A automated DNA sequencer utilizing dye-
labeled dideoxy nucleotides, Taq polymerase, and dou-
ble-stranded DNA, purified by the Promega PCR puri-
fication kit, at the University of Michigan Biomedical
Research Resources Core Facility. A culture of the trans-
formed cells (1 ml, OD600 = 0.5) was mixed with 500
ul of 50% glycerol and stored at -85°C.
2.2. Isolation and Solubilization of Recombinant
ACCO Inclusion Bodies
An E. coli BL21(DE 3) colony harboring the plas-
mid pT7-7-EFE, selected from a 1-day-old LB-Amp
plate, was grown to an OD600 = 0.5 in 5 ml of 2 X TY
medium. The preparative medium (2 X TY containing
100 ug/ml ampicillin) was inoculated with 1 ml of the
above culture per 200 ml of media. The cultures were
incubated at 37°C with vigorous shaking (300 rpm) in
2-L baffled flasks (200 ml/flask) to an OD600 = 0.8 and
IPTG was added (0.2 mM final). The incubation (37°C,
300 rpm) was continued for exactly 4 hr. The cells were
harvested by centrifugation (4500 X g, 15 min) and
stored at -20°C until use. The total wet weight of the
cells was 3-4 g/L of 2 X TY. Frozen cells (from 1 L of
culture) were suspended in lysis buffer (50 mM Tris-
HC1, pH 8, 100 mM NaCl, 1 mM DTT, and 1 mM
EDTA). The cell suspension was sonicated at 4°C using
a Model W-220 sonicator (Heat Systems, Ultrasonics
Inc.) with three 15-sec bursts, and centrifuged at 27,000
X g for 15 min. The pellet was washed twice with lysis
buffer and centrifuged as above. To remove contami-
nating material that would copurify with ACCO, the pel-
let (ACCO inclusion bodies) was resuspended in 50 ml
of lysis buffer containing 0.5% octyl-B-D-glycopyrano-
side, incubated for 30 min at 4°C, sonicated at 4°C with
two 15-sec bursts, and centrifuged at 6000 X g for 15
min. The inclusion bodies washing procedure was re-
peated at least twice. The ACCO inclusion bodies were
suspended in lysis buffer containing 6 M guanidinium
hydrochloride at a protein concentration of 2 mg/ml. The
suspension was incubated for 1-2 hr at 4°C and centri-
fuged at 5000 X g for 10 min to remove insoluble ma-
terial. The solubilized material (mostly ACCO) was
diluted to 300 ug/ml and dialyzed overnight against
three changes of 50 mM Tris-HCl (pH 8) containing 100
mM NaCl and 1 mM DTT. The sample was further di-
alyzed in 10 mM HEPES, pH 7, containing 1 mM DTT
and then concentrated by ultrafiltration to a protein con-
centration of 5 mg/ml and stored at -80°C. Alterna-
tively, the inclusion bodies were suspended in 2%
sodium deoxycholate in lysis buffer. The suspension was
incubated for 1-2 hr at 4°C with continuous stirring,
sonicated at 4°C with two 15-sec bursts, and centrifuged
at 5000 X g for 10 min. This cycle of resuspension,
sonication, and centrifugation was repeated at least
twice. The combined solubilized extracts were applied
to a Sephadex G-25 desalting column equilibrated with
10 mM HEPES, pH 7, containing 1 mM DTT. The flow
through fractions containing ACCO were pooled, dia-
lyzed overnight against three changes of equilibration
buffer, and concentrated by ultrafiltration to a protein
concentration of 5 mg/ml on an Amicon PM-10 unit and
stored at -85°C.
2.3. ACCO Assays
Method 1. The assay mixture contained, in a total
volume of 1.0 ml, 100 mM HEPES (pH 7), 1 mM ACC,
1 mM sodium ascorbate, 100 uM ferrous sulfate, 4 mM
sodium bicarbonate, and enzyme (10-25 ug protein).
The reactions were carried out in 6-ml culture tubes
sealed with rubber septa. After 20 min of incubation at
30°C, a 1-ml sample was withdrawn from the headspace
of each tube and analyzed on a Varian 2400 gas chro-
matograph. The GC was equipped with a flame ioniza-
tion detector and a stainless steel column (18 X 1/8 in)
packed with Porapack R 80/100 mesh, operating at oven,
injector, and detector temperatures of 60, 180, and
280°C, respectively. The ethylene produced in the head-
space of the tube was quantitated by comparison with
an authentic ethylene standard (5 ppm/injection). One
unit of enzyme activity is defined as 1 nmol of ethylene
produced per min (Fernandez-Maculet and Yang, 1992).
Method 2. The assay was performed as described
above except that the 1.0-ml assay mixture contained in
addition to the above reactants 10% glycerol, 500 mg cat-
alase, 100 mg BSA, and 2 mM DTT (Zhang et al., 1995).
2.4. Modification of ACCO with
Diethylpyrocarbonate
Stock solutions of diethylpyrocarbonate (DEPC)
were freshly prepared in dry ethanol (100%) immedi-
ately before use. The concentration of DEPC was deter-
mined spectrophotometrically by measuring the increase
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in absorbance at 240 nm in 10 mM imidazole, 100 mM
HEPES, pH 7. The extension coefficient is 3200 M-1
cm-1 (Melchior and Fahmey, 1970). The inactivation of
ACCO was performed in a reaction mixture containing
12 uM ACCO (enzyme), 100 mM HEPES (pH 7), and
DEPC (10 ul/ml). At time intervals, aliquots were re-
moved and assayed for residual enzyme activity as de-
scribed above.
2.5. Fluorescence Spectroscopy
Fluorescence spectra were performed on a Perkin-
Elmer LS-50 Luminescence Spectrometer. Freshly pre-
pared ACCO solutions (27 ug/ml) in 10 mM HEPES,
pH 7, were placed in a 10 X 10 mm2 quartz cuvettes
and the cell temperature maintained at 25°C. The exci-
tation wavelength was 278 nm and the emission spectra
were recorded between 300 and 400 nm using a band
width of 5 nm.
2.6. Analytical Procedures
Sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis was carried out under reducing conditions on
12% vertical slab gels according to the method of Lae-
mmli (1970). After electrophoresis, the samples were
stained with 0.25% Coomassie brilliant blue R-250. Pro-
tein concentrations in cell lysate, inclusion bodies, and
soluble enzyme preparations were determined by a dye
binding assay (Bio-Rad Laboratories, Richmond, CA)
using bovine serum albumin as a standard. The molec-
ular weight of the recombinant ACCO was determined
by electrospray mass spectra performed by the Univer-
sity of Michigan Biomedical Research Resources Core
Facility. The amino acid composition and N-terminal se-
quence analysis of recombinant ACCO were determined
by the University of Michigan Biomedical Research Re-
sources Core Facility utilizing an Applied Biosystems
420 analyzer equipped with a Model 130 HPLC unit.
The ten amino-terminal amino acids were sequenced by
the University of Michigan Biomedical Research Re-
sources Core Facility via an Applied Biosystems 473
analyzer.
2.7. Site-Directed Mutagenesis
The histidine-to-alanine mutant genes were pre-
pared by a modified PCR method (Chen and Przybyla,
1994) using the following mutagenic primers (desig-
nated Pm): H39A, 5'-GTTGGTGAACGCTGG-
AATTCC-31 (eliminates an Ncol site); H177A, 5'-
CCGCGCTGCTACAGACGCAGGAGG-3' (introduces
a new BsoFl restriction site); H211A, 5'-GGTCAC-
CAAGGTTAACCACAATAGACGCGCGCATGGGA-
GGAACATCG-3' (non-reading frame, introduces a new
BssHll restriction site); and H234A, 5'-GTGCAATTA-
CTCTGGCCAGCACAC-3' (non-reading frame, intro-
duces a new Mscl restriction site). The nucleotides
replaced from the wild-type (the pRC13 sequence of the
plasmid pT7-7-EFE constructed above) gene are in bold.
The common forward primer (upstream of the 5' portion
of the coding region of ACCO) was the commercially
available T7 sequencing primer, 5'-TAATACGACT-
CACTATAGGG-3' (designated PI). The common re-
verse primer (non-reading frame) (downstream of the 3'
end) was 5'-GCATTGGTAACTGTCAGACC-3' (desig-
nated P2). The synthetic mutagenic primer (Pm) con-
taining the desired mutagenic change and P2 for the two
mutants H39A and H177A and PI for mutants H211A
and H234A were used for the first round of PCR am-
plification using wild-type plasmid pYTE2 as template
and Vent DNA polymerase. The amplification was per-
formed for 25 cycles at 94°C for 1 min, 55°C for 1 min,
and 72°C for 1.5 min. Following the last cycle, the re-
action mixture was held at 72°C for 5 min. The proper
base-sized fragments from the first round of PCR were
purified by electrophoresis on 1% low-melting agarose
gel using 0.5 X TAB buffer. The excised bands (mini-
mum amount of gel) were used directly as primers (in
the double-stranded form) together with the alternate pri-
mer (P1 for the first two mutants and P2 for H211A and
H234A) to amplify a second round of DNA synthesis.
The wild-type plasmid pYTE2 was again used as tem-
plate with Vent DNA polymerase. The inclusion of ad-
ditional MgSO4 to compensate for the EDTA carried
over from the LM agarose gel greatly improved the
yields in the second amplification step. The newly am-
plified DNA was purified by LM agarose gel electro-
phoresis and eluted from the gel. The purified DNA was
digested with Ndel and HinDlll and ligated into the ex-
pression plasmid pT7-7 digested with the same two re-
striction enzymes. The ligation mixture was used to
transform chemically competent BL 21 E. coli cells.
The histidine-to-glycine mutant genes were pre-
pared utilizing a new parental strand-only replication
methodology (Weiner and Costa, 1994; Weiner, et al.,
1994). Miniprep wild-type plasmid DNA (pT7-7-EFE)
and two oligonucleotide primers, each containing the de-
sired mutagenic replacement codon (one the exact com-
plement of the other), for each mutant were temperature
cycled 15 times with high-fidelity Pfu (or Vent) DNA
polymerase in the present of buffer and dNTPs utilizing
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the cycle program of 94°C for 1 min, 45°C for 1 min,
and 72°C for 3.5 min according to the procedure sup-
plied by the company with the kit. The reading frame
mutagenic primers for the mutant ACCOs were H177G,
CAAGGGACTCCGCGCTGGTACAGACGCAGGAGGC
(introduces a new Rsal restriction site); H211G, CGA-
TGTTCCTCCCATGCGCGGCTCTATTGTGGTTAACC
(eliminates a Hphl site); and H234G, GTACAAGA-
GTGTGCTGGGCAGAGTAATTGCACAAAC (elimi-
nates a Bbvl site). The thermal-cycled reaction mixture
containing the mutated plasmid with staggered nicks was
treated with Dpnl to digest the parental DNA template,
pT7-7-EFE. The Dpnl digestion reaction mixture, con-
taining the nicked mutagenic DNA, was used to trans-
form supercompetent XL1-Blue E. coli cells supplied
with the kit.
The isolated purified mutant plasmid DNA from
each of the above clones was characterized by first re-
striction digestion and then DNA sequencing. DNA con-
taining the proper mutagenic sequence was used to
transform chemically competent BL21(DE 3) E. coli
cells for the expression of the desired mutant protein. A
culture of the transformed cells (1 ml, OD600 = 0.5) was
mixed with 1 ml of 50% glycerol and stored at -85°C.
2.10. Circular Dichroism Studies
The circular dichroism spectra of the wild-type
ACCO and the mutant enzymes were obtained by scan-
ning the sample solutions in a 1-mm stoppered strain-
free quartz cuvette over the far-UV range (250-185) at
25°C using an Aviv Circular Dichroism Spectrophotom-
eter Model 62 DS containing a water jacket attached to
a circulating water bath. All protein samples were de-
salted on a Sephadex G-25 column equilibrated with 2
mM potassium phosphate buffer (pH 7.5). Protein con-
centrations in column fractions were adjusted to 0.1 mg
per ml. Scans were collected at 1-nm intervals with a
band width of 1.5 run and a dwell time of 1 sec. The
dynode voltage remained below 600 V for all samples.
A total of five readings for each nm measured were av-
eraged for each scan and a total of five scans were col-
lected for each protein solution, the signal averaged,
calibrated to remove the background of the buffer, and
smoothed using the program supplied with the spectrom-
eter (the smoothing program gave a value which was
similar to the Q test @ 99% and 95% CL). The esti-
mated percentages of secondary structure were calcu-
lated from the CD spectra utilizing the self-consistent
method (SELCON program) described by Sreerama and
Woody (1993).
2.8. Mutant Ethylene Preparation and Purification
E. coli containing the H -> A and H -> G ACCO
mutant sequences were grown, and the mutant protein
isolated and purified as the apo-protein from the inclu-
sion bodies by the methods described for the recombi-
nant wild-type ACCO. The activities of these mutants
were determined as described above in Method 1.
2.9. Imidazole Rescue Studies
The histidine mutants H177A, H177G, H211A,
H211G, H234A, and H234G were individually incu-
bated with 100 mM HEPES (pH 7) containing 50 mM
imidazole at 4°C for 30 min and then assayed by Method
1 except that the final assay mixture contained 50 mM
imidazole. The histidine mutants H211G and H234G
were purified using the same procedure as described
above (2% sodium deoxycholate in lysis buffer) for
wild-type ACCO except that 50 mM imidazole was in-
cluded in all buffers used in the purification procedure.
The H211G and H234G mutants, purified by inclusion
of imidazole in the buffers, were assayed by Method 1;
the final assay mixture contained 50 mM imidazole.
3. RESULTS
3.1. Overexpression and Purification of ACC and
ACC Mutants
The synthetic gene, obtained by PCR amplification
using a pYES plasmid containing the pRC13 sequence
[Lycopersicon esculentum (tomato)] as template, was ul-
timately cloned into the Ndel and Bam HI restriction
sites of the expression vector, pT7-7, designed to utilize
T7 DNA polymerase to direct transcription of the target
gene. Overexpression of ACCO from the E. coli strain
BL 21 (DE 3) containing the pT7-7-EFE, after induction
with IPTG, allowed the production of 150-250 mg of
ACC oxidase per 3-4 g (wet weight) of E. coli cells
from 1 L of 2 X TY. Recombinant ACCO overexpres-
sed in E. coli was isolated in the form of insoluble ag-
gregates or inclusion bodies. The distribution of ACCO
in whole cells, supernatant, and pellet fractions was ex-
amined with reducing SDS-PAGE (gel not shown). More
than 20% of total protein in whole-cell lysate was recov-
ered as ACCO. The enzyme was virtually absent in the
supernatant, whereas the pellet fractions contained mostly
ACCO, suggesting that the enzyme accumulated in the
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form of insoluble aggregates or inclusion bodies. ACCO
was obtained at >95% purity after cycles of low-speed
centrifugation and resuspension in lysis buffer containing
0.5% octyl-B-D-glucopyranoside to remove contaminating
proteins from the inclusion bodies preparation.
The solubilized ACCO inclusion bodies were ex-
amined by running the resulting supernatant after cen-
trifugation on reducing SDS-PAGE. The results showed
that ACCO inclusion bodies were completely solubilized
after denaturation in 6 M guanidinium hydrochloride
(data not shown). The soluble material showed no de-
tectable ACCO activity and displayed the emission spec-
tra characteristic of a denatured protein. The unfolded
protein was refolded by dialysis. The folding of ACCO
was confirmed by the recovery of enzyme activity with
a specific activity of 14 units/mg, a value comparable to
that previously reported for the native enzyme (Dilley et
al., 1993, Dong et al., 1992, Zhang et al., 1995).
The ACCO inclusion bodies were solubilized with-
out denaturation with 2% sodium deoxycholate in lysis
buffer by repeated cycles of resuspension in solubiliza-
tion buffer, sonication, and low-speed centrifugation
(5000 X g for 10 min). The soluble fractions contained
>90% of the ACCO present in the inclusion bodies. The
solubilized protein exhibited a specific activity of 14 nmol
of ethylene/min/mg protein and an emission spectrum
characteristic of a native protein. In addition, the solubi-
lized sample was 95% pure as judged by SDS-PAGE and
migrated as a 35-kDa protein (gel not shown).
3.2. Fluorescence Spectroscopy
The unfolding and refolding of ACCO was moni-
tored by intrinsic fluorescence. The emission spectra ob-
tained between 300 and 400 nm were performed at Lex
= 278 nm. When excited, the native protein (solubilized
with sodium deoxycholate) and the refolded protein ex-
hibited fluorescence maxima of 336 and 338 nm, re-
spectively, characteristic of a tryptophan side chain
partially shielded from the aqueous solvent (data not
shown). Unfolding by the addition of 6 M guanidinium
hydrochloride resulted in a red-shifted Lem to 352 nm
(data not shown).
3.3. Molecular Properties
The amino acid composition, the N-terminal se-
quence, and the molecular weight of recombinant ACCO
were performed at the University of Michigan Biomed-
ical Research Resources Core Facility. The molecular
weight was determined by electrospray mass spectros-
copy and shown to be 35,802 ± 11 (predicted 35,813,
spectra not shown). The molecular weight was 35,000
as determined by SDS-PAGE. The N-terminal sequence
obtained, MENFPIINLE, is consistent with that pre-
dicted from the DNA sequence.
3.4. Effect of Preincubating ACCO with Fe2+ on
Enzyme Activity
Incubation of ACCO aerobically with 100 uM Fe2+
without substrate and other cofactors at 30°C for 30 min
resulted in 78% inhibition of enzyme activity (Table I).
Preincubation of the enzyme with Fe2+ under similar
conditions, except for the addition of ascorbate, resulted
in >90% loss of enzyme activity. ACCO was protected
from inactivation by Fe2+ plus ascorbate either by the
inclusion of ACC in the preincubation mixture or by
flushing the solution with nitrogen during the preincu-
bation period (Table I). In contrast, ascorbate or HCO3-
did not inhibit ethylene production when preincubated
separately with ACCO (Table I).
3.5. Inactivation of ACCO by DEPC
Since DEPC hydrolyzes in aqueous solutions, the
inactivation process is corrected for the hydrolysis of
DEPC in buffer and is described by the following equa-
tion:
where A/A0 is the percent activity remaining at time t, I0
is the initial concentration of DEPC, K' is the second-
order rate constant for the inactivation of ACCO by
DEPC, and K' is the pseudo first-order rate constant for
the hydrolysis of DEPC (Gomi and Fujioka, 1983). To
estimate the value of K', DEPC was incubated in 100
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earlier studies involving the inactivation of the histidines
of ACCO performed the experiments in phosphate buf-
fer (Zhang et al., 1995). The value of K' in HEPES was
estimated to be 0.012 min-1. Plots of In (A/A0) versus (1
- e-k't)/K' at various DEPC concentrations were linear
(Fig. 1A). The inactivation process followed pseudo
first-order rate kinetics (Fig. 1A). The second-order rate
constant k for the inactivation was obtained from the
slope of the plot of kobs versus DEPC concentration (Fig.
IB), yielding a k value of 170 min-1 M - 1 . The kobs was
obtained from the slopes of the linear plots in Fig. 1A.
The linearity of the plot with zero origin (Fig. 1B) is
indicative of an irreversible complex formation between
the enzyme and DEPC (Gomi and Fujioka, 1983).
In order to determine the number of essential his-
tidine residues required for ACC oxidation, the log of
the reciprocal of half-life of inactivation (1000/t0.5) was
plotted against the log of DEPC concentration, where
kobs is substituted for by the reciprocal of half-life
(Church et al., 1985; Blanke and Hager, 1990). As
shown in Fig. 1C, the plot was linear with a slope of
0.86, indicating that approximately 1 mol of histidine
was modified per mol of DEPC.
Fig. 1. Kinetics of inactivation of ACCO by diethylpyrocarbonate. (A)
ACCO (12 uM) was incubated with 0.25 (T), 0.5 (•), 1.0 (C), 1.5
(g), or 2.0 (T) mM of DEPC at 4°C. At intervals, aliquots were re-
moved and assayed for residual enzyme activity as described in Sec-
tion 2. The data were plotted according to Equation (1). (B)
Determination of the second-order rate constant. The pseudo first-order
rate constant kobs obtained from panel A at different concentrations of
inhibitor were plotted against DEPC concentration. (C) A plot of the
reciprocal of the half-life of inactivation versus DEPC concentration
on a log-log scale. The reaction order was obtained from the slope of
this plot, following the procedure of Blanke and Hager (1990).
mM HEPES (pH 7) at 4°C. At time intervals, aliquots
were removed and assayed for DEPC by reaction with
imidazole as described in Section 2. Although it has
been reported (Miles, 1977) that DEPC is most stable in
phosphate buffer, HEPES was used instead because
phosphate interferes with ACCO activity. Unfortunately,
where Ka is the acidic dissociation constant of the
reacting group and kobs(max) the pseudo first-order rate
constant of the unprotonated group (Takeuchi et al.,
1986). The pseudo first-order rate constant of inactiva-
tion kobs at various pH values is obtained from the plots
of residual enzyme activity versus time. The experimen-
tally determined kobs values were plotted against pH (Fig.
2A, closed circles) according to Equation (2). The kobs
values at different pH values were used to plot Fig. 2B
according to Equation (3). A pKa value of 6.05 and a
kobs(max) value of 0.186 min
-1 were obtained from the
slope of the line and from the ordinate intercept, respec-
tively (Fig. 2B). The pKa and kobs(max) values were fit to
Equation (2) to construct the theoretical pH dependence
curve (Fig. 2A, solid line, open circles). This pH de-
pendence result, a pKa value of 6.05, strongly suggests
3.6. pH Dependence of Inactivation
DEPC inactivation of ACCO was studied in the pH
range of 5.5-7.8 in HEPES buffer according to the fol-
lowing equation:
Equation (2) is rearranged to the following linear form:
3.7. Substrate Protection of ACCO against
Inactivation with DEPC
The ability of substrates and cofactors to protect
against inhibition of ACCO by DEPC was evaluated and
the results are shown in Fig. 3. Neither ascorbate nor
NaHCO3 provided any protection against inactivation by
DEPC. ACC alone after a 16-min pretreatment, provided
little protection. Iron(II) alone afforded protection
against inactivation. The best protection was obtained
with ACC and Fe2+ together. These results suggest that
Fe2+ or Fe2+ plus ACC binds to a histidine(s) at or near
the active site of the ACCO.
3.8. Reaction with Hydroxylamine
Addition of excess hydroxylamine to DEPC-treated
ACCO could reverse the inactivation of ACCO by
DEPC, depending on the time of addition or degree of
inactivation. As shown in Table II, the majority of en-
zyme activity could be recovered by treatment with hy-
droxylamine when ACCO had only lost 50% of enzyme
Fig. 2. The pH dependence of inactivation. (A) ACCO (12 uM) was
incubated with 1.0 mM diethylpyrocarbonate at various pH values.
The kobs was determined as described in the Section 3 and plotted
against pH. The solid line (with open circles) represents the pH the-
oretical curve and closed circles represent the experimental data (see
text for details). (B) The kobs values shown in panel A were plotted
according to Equation (3). The experimentally determined Ka value
(obtained from the slope of the plot) and kobs(max) (obtained from the x
intercept) were used to plot the pH theoretical curve shown in panel
A according to Equation (2).
that DEPC inactivation of ACCO is due to the modifi-
cation of histidine residues.
Fig. 3. Substrate protection against DEPC inactivation of ACCO.
ACCO (12 uM) was incubated with 1.0 mM diethylpyrocarbonate in
the presence of different substrates in 100 mM HEPES, pH 7, at 4°C.
(•) No substrates added, (D) 1.0 mM ascorbate, (T) 1.0 mM NaHCO,,
(o) 0.1 mM Fe2+, (g) 1.0 mM ACC, and (•) Fe2+ and ACC. At
intervals, aliquots were removed and assayed for ACCO activity as
described in Section 2. Activities were expressed as percentage of the
initial activity of untreated enzyme.
62 Tayeh et al.






















aACCO (12 uM) was incubated with 1 mM DEPC for 4 and 8 min.
DEPC-treated and untreated enzymes were incubated with 0.3 M
hydroxylamine solution (pH 7). All incubations were performed at
4°C. After 20 hr of incubation, aliquots were removed and assayed
for ACCO activity.
b Time of incubation of ACCO with DEPC in 100 mM HEPES buffer
(pH 7) at 4°C.
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loss of enzyme activity (Fig. 4A). The results indicate
that total loss of enzyme activity is associated with the
modification of all seven histidine residues. This means
that all histidine residues are accessible for the DEPC.
Therefore, to determine the number of essential histidine
residues, the method developed by Tsou (1962) was
used. The relationship for remaining activity as a func-
tion of histidine modification is given by
where a is the fractional activity remaining when m his-
tidines have reacted, p is 7 (the total number of histidines
in ACCO), and u is the number of critical histidines.
The results of such a treatment of the data are shown in
Fig. 4B. The number of essential histidine residues was
found to be one.
3.10. Site-Directed Mutagenesis of ACCO
The four histidine-to-alanine ACCO mutants were
constructed using the three-primer, two-step PCR-based
mutagenesis procedure previously reported (Chen and
Przybyla, 1994). The three histidine-to-glycine ACCO
mutants were constructed using the method recently re-
ported by Weiner (the QuikChange Site-directed Muta-
genesis Kit marketed by Stratagene contains instructions
and everything needed for this procedure except the mu-
tagenic primers) (Weiner and Costa, 1994; Weiner et al.,
1994). The incorporation of the mutation into the target
DNA regardless of the method of production was first
confirmed by restriction digestion (see experimental sec-
tion) and then by DNA sequencing. The histidine-to-
alanine/glycine mutagenic proteins were overproduced
from the pT7-7-based vectors containing the desired
DNA mutagenic sequence as previously described for
the overproduction of wild-type recombinant ACCO,
and purified to >95% homogeneity, as assessed by
SDS-polyacrylamide gel electrophoresis. The mutants
were isolated as inclusion bodies as was the wild-type
ACCO. The H39A mutant protein had an activity similar
to that of wild-type ACCO (Table III). The activity of
the H177A, H177G, H211A, H211G, H234A, and
H234G mutants was greatly reduced or totally elimi-
nated, as can be seen in Table III. Since E. coli does not
produce ethylene, there is no problem of contamination
of the mutant ACCO with background wild-type ACCO.
3.11. Imidazole Rescue Studies
The activity of the H177A, H177G, H211A,
H211G, H234A, and H234G mutants was determined,
Fig. 4. Correlation of the number of histidine residues modified with
enzyme activity. (A) ACCO (10 uM) was incubated with 1.0 mM
DEPC (diluted in absolute ethanol) in 100 mM HEPES, pH 7. A ref-
erence sample contained an equivalent amount of ethanol without
DEPC. The residual enzyme activity (•) and A240 (g) were plotted as
a function of time. (B) Correlation between the number of modified
histidine residues and the remaining activity of the enzyme. The data
are presented in the form of a Tsou plot where u = 1 (D), 2 (T),
and 3 (S).
activity. However, only 42% of enzyme activity could
be recovered by hydroxylamine, when only 76% of re-
sidual activity had been lost.
3.9. Correlation between Enzyme Activity and
Histidine Residues Modified by
Diethylpyrocarbonate.
ACCO contains seven histidine residues in its pri-
mary structure as predicted from its cDNA sequence
(Hamilton et al., 1991) and as determined from the total
amino acid analysis performed on the recombinant
ACCO (data not shown). The number of histidine resi-
dues modified by DEPC as determined by the difference
spectra at 240 nm (data not shown) correlates with the
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after preincubating each mutant with 50 mM imidazole
for 30 min at 4°C, utilizing Method 1 except that 50 mM
imidazole was included in the assay mixture. The eth-
ylene-forming activity of the mutants preincubated with
imidazole was the same as the corresponding mutants
that had not been preincubated or assayed in the pres-
ence of imidazole. To determine if the addition of ex-
ogenous imidazole into the buffers used during the
purification scheme would lead to incorporation of the
imidazole (thus the restoration of ethylene-forming ac-
tivity) by the mutant ACCO, 50 mM imidazole was added
to all buffers (breaking, washing, and lysis buffer) for the
purification of the mutants H211G and H234G from the
frozen E. coli pellets. The enzymatic activity of H211G
and H234G remained the same as the activity of H211G
and H234G purified in the absence of imidazole.
3.12. Circular Dichroism Studies
The conformational integrity of the mutant ACCO
was probed by circular dichroism spectroscopy. The CD
spectra of the wild-type ACCO and the eight mutants
indicate modest but significant conformational changes
in some of the mutant enzymes. Since ACCO is isolated
in the apo form from the inclusion bodies, the CD spec-
tra obtained were with the apo enzyme. The CD of the
two mutants isolated in the presence of imidazole was
identical to the CD of the corresponding mutants isolated
in the absence of imidazole. The deconvolution of the
spectral data by the self-consistency method of Sreerama
and Woody (1993) is shown in Table III. The results of
analysis of the CD data with other deconvolution pro-
grams were consistent with these values (data not shown).
4. DISCUSSION
In the present report, we describe the isolation of
Lycopersicon esculentum (tomato) ACCO from E. coli
BL21(DE3) containing pT7-7-EFE. The ACCO, which
accounts for >25% of the total cellular protein, is re-
covered in the form of inclusion bodies. Cell breakage
followed by low-speed centrifugation results in the total
recovery of ACCO-containing inclusion bodies in the
pellet fraction, while contaminating soluble protein and
nonproteinaceous material that remain in the supernatant
are easily removed. It has been previously reported that
heterologous proteins, when highly expressed in E. coli,
accumulate in the form of aggregates or inclusion bodies
(Marston, 1986; Marston and Hartley, 1990). At a con-
centration of 0.5%, the detergent octyl-B-D-glucopyra-
noside solubilized the remaining contaminating proteins,
but not ACCO. The ACCO inclusion bodies could there-
fore be isolated in >95% purity by repeated cycles of
washing with 0.5% octyl-B-D-glucopyranoside and low-
speed centrifugation. It seems quite advantageous for
ACCO to accumulate as inclusion bodies in its apo form
since purification of ACCO for biochemical characteri-
zation does not require the laborious three-column chro-
matographic procedures recently reported (Zhang et al.,
1995), and in the absence of Fe2+ one does not have to
perform the enzyme purification anaerobically or in the
presence of various metal chelators in all the buffers. In
addition, it has been reported that holo-ACCO is quite
unstable in the presence of oxygen.
Solubilization of highly overexpressed proteins from
inclusion bodies utilizing mild conditions, such as extrac-
tion with sodium deoxycholate, has previously proven to
be unsuccessful; however, sodium deoxycholate at con-
centrations of 0.5% has been employed for the extraction
of lipids, nucleic acids, and minor protein contaminants
from these inclusion bodies (Marston, 1989). In the pres-
ent study, ACCO inclusion bodies have been successfully
solubilized with 2% sodium deoxycholate. Approximately
60 mg of pure soluble ACCO/g of E. coli cells containing
the pT7-7-EFE plasmid is obtained on a routine basis.
Even at 0.5% deoxycholate, 40% solubilization of ACCO
can be achieved. To completely free the sample of deox-
ycholate, it is necessary to perform both Sephadex G-25
chromatography and dialysis.
The results obtained from the analytical analyses of
the solubilized recombinant ACCO are consistent with
those from studies involving native ACCO with one no-
table exception. In contrast to native ACCO obtained
from apple, the mature recombinant tomato ACCO retains
the N-terminal methionine (Pirrung et al., 1993). The
somewhat enhanced specific activity of the present ACCO
could be due to the fact that the ACCO contained in in-
clusion bodies is apo (i.e., it does not contain Fe2+) and





























































a Determined by the method of Sreerama and Woody (1993).
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that such large quantities of ACCO are present in the
inclusion bodies. It has been shown recently that ACCO
is quite unstable in the presence of oxygen, ascorbate, and
iron(II) due to oxidative damage (Barlow et al., 1997).
To explore the role of histidine(s) at the active site
of various enzymes, the active-site modification reagent
diethylpyrocarbonate (DEPC) has been employed (Bhat-
tacharyya et al., 1993; Cheng and Nowak, 1989; Church
et al., 1985; Fukumori and Hausinger, 1993a, b; Le-
maire et al., 1994; Lundblad and Noyes, 1984; Saluja
and McFadden, 1980, 1982; Takeuchi et al., 1986). In
the present work, we have attempted to identify the role
of histidine in ACCO catalysis by both chemical and
kinetic studies using DEPC. Chemical studies have
shown that ACCO is inactivated by DEPC in a time-
dependent manner. Kinetic studies revealed that the re-
action between DEPC and ACCO is bimolecular (Church
et al., 1985) and followed pseudo first-order kinetics (Fig.
1A and IB). The second-order rate constant k for inacti-
vation by DEPC is 170 M-1 min-1. This value is in the
range of rate constants obtained for other proteins con-
taining essential histidine residues. These rates vary
widely from a low of 0.67 M-1 min-1 (Bhattacharyya et
al., 1993) to a high of 368 M-' min-1 (Bhattacharyya et
al., 1993; Cheng and Nowak, 1989; Church et al., 1985;
Fukumori and Hausinger, 1993a, b; Lundblad and Noyes,
1984; Miles et al., 1993). The chemical modification stud-
ies with DEPC reveal that while only one histidine resi-
due may be essential for activity, all seven histidines are
ultimately modified by DEPC (Fig. 4B).
DEPC is known to react with lysine and tyrosine
residues as well as histidine residues; therefore, in order
to establish unequivocally that DEPC has reacted only
with the histidine residues in ACCO, a number of cri-
teria must be demonstrated. DEPC is known to modify
selectively histidine residues in the pH range of 5.5-8
(Miles, 1977). The rate of inactivation of ACCO by
DEPC exhibited a pH dependence (Fig. 2A) and the pKa
value of the modified amino acid residue was calculated
to be 6.05 (Fig. 2B). This value is consistent with the
pKa values for histidine modification (Lundblad and
Noyes, 1984; Miles, 1977). Reactivation of DEPC-in-
activated proteins by treatment with hydroxylamine is
indicative of either an ethoxyformylated histidine or ty-
rosine residue, but not an ethoxyformylated lysine (Mel-
chior and Fahrney, 1970; Miles, 1977). Since
hydroxylamine reactivates DEPC-treated ACCO, the in-
volvement of lysine residues in the modification reaction
can most likely be excluded (Table II). This reversibility
of inactivation by DEPC has been observed with a num-
ber of other enzymes (Bhattacharyya et al., 1993;
Church et al., 1985; Daron and Aull, 1982; Lemaire et
al., 1994; Saluja and McFadden, 1980, 1982). In some
enzyme systems where DEPC inactivation is known to
occur via modification of only histidine, inactivation
cannot be reversed by hydroxylamine (Bloxham, 1981;
Bond et al., 1981; Cheng and Nowak, 1989; Cromartie,
1981; Saluja and McFadden, 1982). The explanation
most commonly presented for this lack of reactivation
of the DEPC-modified enzyme in these examples is the
inaccessibility of hydroxylamine to the carbethoxyhisti-
dine-modified moiety or that hydroxylamine itself di-
rectly inactivates the enzyme. DEPC-modified tyrosine
and histidine residues display several distinct spectral
differences. The modification of tyrosine residues by
DEPC can be monitored by spectral changes at A278
(Miles, 1977). In the present study there is no change in
A27S, indicating that the inactivation of ACCO by DEPC
is not caused by the modification of tyrosine residues
(data not shown). The difference ultraviolet spectrum of
DEPC-treated ACCO versus untreated ACCO showed
an increase in absorbance at 240 nm, which is a char-
acteristic of protein-bound ethoxyformyl histidine
(Lundblad and Noyes, 1984; Miles, 1977) and not an
ethoxyformyl tyrosine. Finally, protection against DEPC
modification of ACCO by the cofactor Fe2+ and one of
the substrates, ACC, suggests that the reactive-site his-
tidine residues are most likely at or near the Fe2+-binding
site, indicating that histidine residues in ACCO are li-
gands for the Fe2+ binding and are the amino acid resi-
dues being modified (Fig. 3). The enhanced protection
by ACC suggests that ACC may also act as a ligand to
Fe2+. None of the other cofactors or substrates afforded
protection against inactivation (Fig. 3). Zhang et al.
(1995) failed to detect protection against DEPC inacti-
vation by just Fe2+, although they found that Fe2+ did
provide protection, but only in the presence of ACC and
ascorbate. The discrepancy between results is probably
due to the difference in the assay conditions used for
ACCO. The Schofield group (Zhang et al., 1995) used
phosphate buffer for the inactivation studies; however,
we have found that phosphate interferes with ACCO ac-
tivity assays and thus we used HEPES instead of phos-
phate. The pH dependence of inactivation, the
reactivation of DEPC-inactivated ACCO by hydroxyla-
mine, the UV spectral results, and the substrate protec-
tion studies strongly suggest that DEPC modified only
histidine residues in ACCO and that these histidines and
ACC are ligands to the active-site iron.
In order to determine which histidine(s) is (are) po-
tentially involved in the binding of the iron at the active
site of ACCO, several histidine residues were chosen for
mutagenic studies. Which of the seven histidines in
ACCO to mutate was based on amino acid sequence
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homology comparisons with members of the nonheme
ferrous-dependent oxidase/oxygenase superfamily such
as flavanone-3B-hydroxylase, isopenicillin-N-synthase
(IPNS), maize A2 locus gene, hyoscyamine-6B-hydrox-
ylase, and deacetoxycephalosporin-C-synthetase as pre-
viously described (Hamilton et al., 1991; Matsuda et al.,
1991) as well as with 13 known ACCO amino acid se-
quences (alignments not shown). Histidine 177 and 234
were obvious choices based on these homologies as well
as the X-ray structure of one of its well-studied mem-
bers, IPNS (Roach et al., 1995, 1997). Histidine 39 was
chosen based only on homology with the superfamily,
whereas histidine 211 was chosen based on its absence
from the superfamily, but its conservation within the
ACCO family. During the characterization of these to-
mato histidine mutants, a report (Shaw et al., 1996) ap-
peared indicating that HI77, D179, and H234 of the
apple fruit ACCO may be putative ferrous-binding li-
gands. These conclusions were based on mutation stud-
ies of each of the respective amino acids. The fact that
HI77 and H234 in both apple and tomato ACCO are
potentially involved in ferrous binding is not surprising
based on their sequence homology with IPNS. The X-ray
crystal structure of IPNS clearly demonstrates that two
histidines, H214 and H270, corresponding to HI77 and
H234 in ACCO, are involved in the ligation of the metal.
The concept of restoration of catalytic activity by
addition of exogenous small organic molecules, origi-
nally reported by Toney and Kirsch (1989) for restora-
tion of activity to the K258A mutant of aspartyl
aminotransferase by the addition of amine, was first uti-
lized to restore catalytic activity to a histidine mutant by
addition of imidazole in the case of the HI 17G mutant
of Ps. aeruginosa azurin (den Blaauwen and Canters,
1993) and since by others (DePillis et al., 1994; Wilks
et al., 1995). Although the methyl group of the alanine
may be too large to allow the replacement with the ex-
ogenous organic molecule to exactly "fit" into the same
space occupied by the original side chain of the amino
acid replaced, it has been reported to work (Wilks et al.,
1995). Unfortunately, in the case of HI 77 A, H211 A, and
H234A, there was no restoration of ethylene-forming ac-
tivity by the preincubation of the mutants with imidazole
and inclusion of imidazole into the assay mixture. As-
suming the reason for lack of recovery of activity was
due to the fact that the methyl group was too big, the
corresponding histidine-to-glycine mutants were pre-
pared. The results were the same: no restoration of ac-
tivity by preincubation with imidazole and inclusion of
imidazole into the assay mixture. In some cases activity
could only be recovered if the exogenous ligand was
included during the isolation procedure, the idea being
that the ligand would be bound into the missing cavity
during purification. The H211G and H234G were puri-
fied in the presence of imidazole and assayed in the pres-
ence of imidazole with the same disappointing results,
no recovery of activity. These results may not be sur-
prising if one examines the crystal structure of IPNS
with its sequence homologies to ACCO in mind. Histi-
dines 214 and 270 of IPNS (equivalent to HI77 and
H234 of ACCO) are located inside the jellyroll motif of
IPNS on a loop region and at the start of a B-sheet,
respectively. Imidazole may be able to chelate with iron
and the mutant ACCOs, but the imidazole is not tethered
to the protein backbone; therefore, the movement of the
exogenous imidazole may not be able to bring about the
necessary structural changes at the active site to allow a
catalytically active site to form. This movement or lack
of movement would not be detected by CD measure-
ments since the replaced histidines are in a variable re-
gion of ACCO. The role of histidine 211 maybe
somewhat more complicated. There is no corresponding
"H211" in IPNS, so its structural location is harder to
predict based on the structure of IPNS. It is clear from
the data presented here, however, that both H211A and
H211G have only 10% the catalytic activity of wild-type
ACCO and that the addition of exogenous imidazole
does not restore activity to either mutant. This seems to
imply some role for H211 similar to the other histidines.
The DEPC chemical modification studies, when an-
alyzed utilizing the Tsou (1962) method, revealed that
the modification of only one histidine is essential for
enzymatic activity. Utilizing site-directed mutagenesis,
it was demonstrated that two other histidines may be
necessary as structural units and that their elimination
rather than simple ethoxyformylation by the DEPC im-
pedes enzyme function. From the strong sequence ho-
mology with IPNS, it can be inferred that HI77 and
H234 are most likely involved with metal binding, while
H211 may be involved mechanistically or structurally in
ACCO activity. In support of this hypothesis, it has been
reported by Zhang et al., (1997) that H211Q is active.
Since glutamine contains functional groups capable of
hydrogen bonding (like histidine) as opposed to either
glycine or alanine (prepared in this study), H211 may
well be involved in either a structural or catalytic role.
In this article, we present evidence that histidine
residues are important for ACCO activity as demon-
strated by the DEPC inactivation studies. From site-di-
rected mutagenesis, we have demonstrated that HI77,
H211, and H234 are important residues for ACCO ac-
tivity. Ming et al. (1991) and Randall et al. (1993) have
shown that two or three histidine residues are involved
in Fe(II) binding in IPNS, which has a high extent of
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homology with ACCO. Histidines 177 and 234 in
ACCO are homologous with H214 and H270 in IPNS,
which were shown by an X-ray crystal structure to be
the metal-binding ligands in IPNS. The fact that ACCO
mutants HI77 and H234 mutants are inactive supports
their proposed role in ACCO based on sequence homol-
ogy with IPNS. For the first time, we were able to dem-
onstrate the importance of H211 for ACCO activity either
structurally or catalytically. The exact role of the three
histidines 177, 211, and 234 is presently under investi-
gation in our laboratory utilizing NMR methodologies.
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